Neurocrine Biosciences, Inc. (NBIX)
155.50
+0.83
(+0.54%)
USD |
NASDAQ |
May 21, 16:00
155.58
+0.08
(+0.05%)
After-Hours: 19:59
Neurocrine Biosciences Accounts Payable (Quarterly) : 120.00M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Soleno Therapeutics, Inc. | 12.39M |
| Biogen, Inc. | 358.50M |
| Nuvalent, Inc. | 22.14M |
| Marker Therapeutics, Inc. | 1.500M |
| Denali Therapeutics, Inc. | 40.38M |